52-week price history of KYTX Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Kyverna Therapeutics Inc.’s current trading price is -52.62% away from its 52-week high, while its distance from the 52-week low is 18.98%. The stock’s price range during this period has fluctuated between $13.96 and $35.06. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.73 million for the day, which was evidently higher than the average daily volume of 0.5 million over the last three months.
Moving average and trading volume data
KYTX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for KYTX stands at 0.18. Similarly, the long-term debt-to-equity ratio is also 0.13.
KYTX Stock Stochastic Average
The raw stochastic average for Kyverna Therapeutics Inc. over the last 50 days is presently at 15.93%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 24.20%. Further, the company’s Stochastic %K and %D values for the last 20 days were 14.86% and 8.65%, respectively.
KYTX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -44.63% since the start of this calendar year. Over the past 30 days, the price of KYTX has leaped by -27.47%. And in the last five days, it has fallen by -6.21%.
